SCHEMBL23939824

SCHEMBL23939824

CCc1cccc(N)c1C(=O)NC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.43
ALDH1A1 P00352 5/20 0.43
PLK1 P53350 3/20 0.42
GABRA1 P14867 2/20 0.41
GABRB2 P47870 2/20 0.41
HPGD P15428 3/20 0.40
CACNA1C Q13936 1/20 0.40
SCN5A Q14524 1/20 0.40
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RCE1 Q9Y256 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
EGFR P00533 1/20 0.36
JAK1 P23458 1/20 0.36
NQO2 P16083 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13354976 0.80 CA12 (0.47) ALDH1A1PLK1GABRA1GABRB2MAPT
SCHEMBL321003 0.79 GABRA1 (0.45) KDM4EALDH1A1GABRA1GABRB2GAA
SCHEMBL14731237 0.79 GAA (0.50) PLK1GABRA1GABRB2GAARAB9A
SCHEMBL8571637 0.79 ALDH1A1 (0.50) KDM4EALDH1A1GABRA1GABRB2HPGD
SCHEMBL2061352 0.78 CD44 (0.43) KDM4EALDH1A1PLK1HPGDGAA
SCHEMBL10174604 0.77 PLK1 (0.41) KDM4EALDH1A1PLK1GABRA1GABRB2
SCHEMBL1202579 0.76 GAA (0.52) ALDH1A1GAARAB9AHDAC1JAK1
SCHEMBL15520067 0.76 HDAC8 (0.42) KDM4EALDH1A1PLK1HPGDGAA
SCHEMBL7457606 0.76 JAK1 (0.58) ALDH1A1HPGDJAK1
SCHEMBL24469675 0.76 GABRA1 (0.42) KDM4EALDH1A1GABRA1GABRB2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2367800-B9 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER IPHARMA H K LTD (HK) 2021-10-20 EP disclosed